-
Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
biospace
April 28, 2018
Q1 2018 Change Change at CER IFRS net sales reported EUR7,898m -8.7% -0.4% IFRS net income reported EUR1,016m -82.2%(2) - IFRS EPS reported EUR0.81 -82.0%(2)
-
Sanofi Quarterly Sales Sluggish with Focus on Integrating Bioverativ and Ablynx
biospace
April 28, 2018
Paris-based?Sanofi?reported?mixed first-quarter revenues, with net sales down 8.7 percent to 7,898 million euros.
-
Sanofi makes ex-Roche scientist new R&D chief
pharmafile
April 26, 2018
With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes it has found the man in John Reed (pictured above).
-
New Sanofi R&D Boss Marks Yet Another High-Profile Industry Executive Change
biospace
April 25, 2018
Paris-based?Sanofi?announced?that?Elias Zerhouni,?head of Global Research and Development, is retiring on June 30. The company has appointed?John Reed?to replace him as of July 1.
-
Sanofi Pasteur’s vaccine facility to be set up in Toronto
expressbpd
April 19, 2018
Governments of Canada and Ontario have announced an investment of up to $70 million towards Sanofi Pasteur’s $500-million project
-
Sanofi ups the ante in vaccines with new €350M plant
fiercepharma
April 18, 2018
Sanofi CEO Olivier Brandicourt took a hard look at the French drugmaker's operations after he took the helm—and he put its vaccines business front and center in the company's growth plans.
-
Sanofi to Sell its Generic Division to Advent for $2.4 Billion
biospace
April 18, 2018
Paris-based?Sanofi?has agreed to?sell?its generics division,?Zentiva, to?Advent International.
-
Sanofi looks to trim down with divestments
pharmafile
April 17, 2018
Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines.
-
Sanofi to invest in Canadian vaccine facility
biospectrumasia
April 16, 2018
The investment bolsters the company's Canadian operations and its commitment to advancing public health around the world.
-
Sanofi to invest €350m in new Canadian vaccine plant
pharmafile
April 13, 2018
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, according to the company, is one of its biggest-ever investments in a single building.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
